| CXSL2300345 | 培集成干扰素α-2注射液 | peginterferon alfacon-2 | Injection | Biological Products(2.2) | New Drug Application | 2023-05-17 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2200459 | 人干扰素α2b喷雾剂 | Recombinant Human Interferon α2b | Spray | Biological Products(2.2) | New Drug Application | 2022-09-14 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYSB2400273 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-10-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB2101717 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2021-08-23 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSB2300020 | 培集成干扰素α-2注射液 | peginterferon alfacon-2 | Injection | Biological Products | Supplementary Application | 2023-02-25 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYSB2400271 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-10-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2200464 | 培集成干扰素α-2注射液 | peginterferon alfacon-2 | Injection | Biological Products(2.2) | New Drug Application | 2022-09-16 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2300038 | KW-027注射液 | KW-027 | Injection | Biological Products(1) | New Drug Application | 2023-01-13 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSS2400105 | 培集成干扰素α-2注射液 | peginterferon alfacon-2 | Injection | Biological Products(2.2) | New Drug Application | 2024-09-30 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYSB2200225 | 培集成干扰素α-2注射液 | peginterferon alfacon-2 | Injection | Biological Products | Supplementary Application | 2022-09-09 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB2101715 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2021-08-23 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2400018 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products(2.2) | New Drug Application | 2024-01-10 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB2101716 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2021-08-23 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB2101714 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2021-08-23 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2400016 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products(2.2) | New Drug Application | 2024-01-09 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYSB2400272 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-10-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB2250441 | 复方甘草酸苷片 | Glycyrrhizin;Glycine;DL-Methionine | Tablet | Chemical Drugs(原6) | Supplementary Application | 2022-07-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYSB2200184 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products | Supplementary Application | 2022-07-28 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| X0302500 | 重组人干扰素α2b滴眼液 | Recombinant Human Interferon α2b | Eye drops | Biological Products(14) | New Drug Application | 2004-01-15 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2004-07-29 | view |
| Y0400019 | 注射用盐酸吡硫醇 | pyritinol hydrochloride | Lyophilized | Chemical Drugs(6) | Generic Drug | 2004-01-08 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2004-08-09 | view |
